Caribou appoints CFO Jason O'Byrne as principal accounting officer; controller Fischesser cedes role

Caribou Biosciences, Inc.

Jason V. O'Byrne, CFO, appointed principal accounting officer effective Dec 15, 2022.
Ryan Fischesser steps down as principal accounting officer but remains VP of Finance and Controller.
Fischesser is no longer an officer for Section 16 purposes as of Dec 15, 2022.
No new arrangements, family relationships, or material transactions tied to the change.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Ryan Fischesser

principal accounting officer

CRBU · Caribou Biosciences, Inc.

Effective: 2022-12-15
Successor: Jason V. O'Byrne
Filed: December 16, 2022, 6:59 PM ET

The Company’s Vice President of Finance and Controller, Ryan Fischesser, who was previously serving as the Company’s principal accounting officer, will continue serving as the Company’s Vice President of Finance and Controller but not as the Company’s principal accounting officer, effective as of December 15, 2022.

Role change

Jason V. O'Byrne

principal accounting officer

CRBU · Caribou Biosciences, Inc.

Effective: 2022-12-15
Filed: December 16, 2022, 6:59 PM ET

On December 15, 2022, Caribou Biosciences, Inc. (the “Company”) appointed Jason V. O’Byrne, its Chief Financial Officer, as the Company’s principal accounting officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ryan Fischesser changed role as principal accounting officer at Caribou Biosciences, Inc..

Action: ceased to serve as
Role: principal accounting officer

Exact text from the filing

The Company’s Vice President of Finance and Controller, Ryan Fischesser, who was previously serving as the Company’s principal accounting officer, will continue serving as the Company’s Vice President of Finance and Controller but not as the Company’s principal accounting officer, effective as of December 15, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jason V. O'Byrne was appointed as principal accounting officer at Caribou Biosciences, Inc..

Action: appointed
Role: principal accounting officer

Exact text from the filing

On December 15, 2022, Caribou Biosciences, Inc. (the “Company”) appointed Jason V. O’Byrne, its Chief Financial Officer, as the Company’s principal accounting officer.

View on SEC.gov

Caribou Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001619856-22-000039

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.